UNSPSC 51372115: Codeine phosphate hemihydrate

This classification denotes an opiate with the molecular formula 2C18H21NO3.H2O.2H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GSL05Y1MN6, chemically known as 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol phosphate (1:1) (salt) hemihydrate but more generally known as codeine phosphate, which bears US NIH Compound Identifier 5359227. European Medicines Agency schedules Codeine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13427MIG.

Most nations, for tariff and trade purposes, schedule codeine phosphate hemihydrate under HS 29391100. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.O.OP(=O)(O)O.OP(=O)(O)O.

UNSPSC 51372115 Codeine phosphate hemihydrate is a Commodity code that in practice captures state and local procurement of pharmaceutical products and related health supplies, though recent opportunities tagged under this code show limited direct alignment with codeine itself. State and local governments soliciting under this code procure generic multi-source pharmaceuticals, over-the-counter products, naloxone, and drug deactivation systems through a mix of issuing bodies: state health departments, cooperative purchasing alliances serving multiple jurisdictions, and county health agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and state health commissions are active repeat buyers, issuing formal RFPs for broad pharmaceutical supply agreements. Scope of work includes establishing supplier relationships for pharmaceutical distribution through authorized wholesalers, managing National Drug Code compliance, and meeting FDA regulatory requirements including current Good Manufacturing Practices certification and Drug Supply Chain Security Act compliance.

Recent activity spans Florida and Minnesota with national reach through cooperative purchasing vehicles. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Minnesota Department of Administration issued MMCAP RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contracts effective July 1, 2026; the RFP weights price competitiveness at 75 percent and requires vendors to maintain relationships with three authorized wholesalers. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels, signaling exploratory procurement activity prior to formal solicitation.